Zonisamide Capsule
Product Images NDC 0615-8266

3 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 0615-8266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Zonisamide 100mg Capsule (Zonisamide Caps 100mg 8266 Invagen For Cipla 1)

Chemical Structure For Zonisamide 100mg Capsule (Zonisamide Caps 100mg 8266 Invagen For Cipla 1)
Chemical structure of zonisamide, showing the arrangement of its molecular components including a benzisoxazole ring with a sulfonamide functional group.*
FDA Label Image

Figure 1 (Zonisamide Caps 100mg 8266 Invagen For Cipla 2)

Figure 1 (Zonisamide Caps 100mg 8266 Invagen For Cipla 2)
A line chart titled 'Proportion of Patients Achieving Differing Levels of Seizure Reduction in Zonisamide and Placebo Groups in Studies 2 and 3'. It shows the percentage reduction in all partial seizures rate on the vertical axis and percentage of patients on the horizontal axis. Two treatment arms are compared: Zonisamide (blue line with circles) and Placebo (orange line with diamonds). The chart also includes a vertical arrow annotating 'No change' at the midpoint and 'Worsening' downward to indicate direction of seizure rate changes.*
FDA Label Image

Principal Display Panel Zonisamide Caps Usp 100 mg (Zonisamide Caps 100mg 8266 Invagen For Cipla 3)

Principal Display Panel Zonisamide Caps Usp 100 mg (Zonisamide Caps 100mg 8266 Invagen For Cipla 3)
This image shows a packaging label for Zonisamide Caps USP 100 mg capsules. The label includes lot and expiration date fields, a quantity indication of 30 capsules, and is labeled for institutional use only. The product is packaged by Vangard Labs, Glasgow, KY, and the label references manufacturing by Invagen for Cipla. Multiple barcodes and storage instructions are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.